[1]
M. Fogh, A. Højgaard, C. Birkmose Rotbøl, and A. Bonde Jensen, “The majority of Danish breast cancer survivors on adjuvant endocrine therapy have clinically relevant sexual dysfunction: a cross-sectional study”, AO, vol. 60, no. 1, pp. 61–68, Jan. 2021.